About Michael Walsh
Michael Walsh is a director at SRT Therapeutics.
Form D filings also name Michael Walsh as a president, secretary and chief financial officer at Evida Biosciences and sits on its board.
Michael Walsh first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Walsh in the role, so the role may have started earlier or lasted longer.
Evida Biosciences Inc.
President, Secretary and Chief Financial Officer, director
2024 · San Diego, CA
Key Colleagues at Startups
The people Michael Walsh works with at each company, as listed on that company's latest Form D.
SRT Therapeutics, Inc. · Form D, Aug 14, 2025
RB
Rolf Benirschke
Director
BD
Brian Feagan, M.D.
Director
EP
Ed Prunchunas
Director
LO
Lauren Otsuki
President and Chief Executive Officer, director
SW
Shierley Widjaja
Director
Evida Biosciences Inc. · Form D, Oct 11, 2024
SG
Scott Glenn
Director
LO
Lauren Otsuki
Director
RB
Rolf Benirschke
Director
SW
Shierley Widjaja
Director
DW
David Wrigley
Director
BD
Brian Feagan, M.D.
Director